This retrospective study evaluated the clinical relevance of the three novel autoantibodies, anti-SP1, anti-CA6, and anti-PSP, in patients with clinically significant aqueous-deficient dry eye who were suspected of having an underlying autoimmune disease, particularly SS. This evidence concerns the gene CA6 and Keratoconjunctivitis sicca.